Amit Kumar Biography and Net Worth

CEO of Anixa Biosciences

Dr. Kumar has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital with OAK Investment Partners, and has been an advisor to investment funds, venture capital firms, and Fortune 500 companies. He was on the Board of Directors of Acacia Research Corporation from 2002-2008. Dr. Kumar is currently Chairman, President and CEO of Anixa Biosciences and he sits on the Board of other public and private companies. He has served on the Board of the American Cancer Society since 2016. He received his AB in Chemistry from Occidental College. After graduate studies at Stanford University and Caltech, he received his Ph.D. from Caltech and followed that with a post-doctoral fellowship at Harvard.

What is Amit Kumar's net worth?: The estimated net worth of Amit Kumar is at least $1.65 million as of June 7th, 2024. Dr. Kumar owns 516,925 shares of Anixa Biosciences stock worth more than $1,654,160 as of November 23rd. This net worth approximation does not reflect any other investments that Dr. Kumar may own. Additionally, Dr. Kumar receives an annual salary of $1,290,000.00 as CEO at Anixa Biosciences. Learn More about Amit Kumar's net worth.
How old is Amit Kumar?: Dr. Kumar is currently 60 years old. There are 3 older executives and no younger executives at Anixa Biosciences. Learn More on Amit Kumar's age.
What is Amit Kumar's salary?: As the CEO of Anixa Biosciences, Inc., Dr. Kumar earns $1,290,000.00 per year. Learn More on Amit Kumar's salary.
How do I contact Amit Kumar?: The corporate mailing address for Dr. Kumar and other Anixa Biosciences executives is 3150 ALMADEN EXPRESSWAY SUITE 250, SAN JOSE CA, 95118. Anixa Biosciences can also be reached via phone at (408) 708-9808 and via email at [email protected]. Learn More on Amit Kumar's contact information.
Has Amit Kumar been buying or selling shares of Anixa Biosciences?: Amit Kumar has not been actively trading shares of Anixa Biosciences during the past quarter. Most recently, on Friday, June 7th, Amit Kumar bought 25,000 shares of Anixa Biosciences stock. The stock was acquired at an average cost of $2.41 per share, with a total value of $60,250.00. Following the completion of the transaction, the chief executive officer now directly owns 516,925 shares of the company's stock, valued at $1,245,789.25. Learn More on Amit Kumar's trading history.
Who are Anixa Biosciences' active insiders?: Anixa Biosciences' insider roster includes Arnold Baskies (Director), Emily Gottschalk (Director), Amit Kumar (CEO), and Lewis Titterton, Jr. (Director). Learn More on Anixa Biosciences' active insiders.
Are insiders buying or selling shares of Anixa Biosciences?: In the last year, Anixa Biosciences insiders bought shares 10 times. They purchased a total of 124,378 shares worth more than $368,077.54. The most recent insider tranaction occured on July, 30th when Director Lewis H Titterton Jr bought 21,646 shares worth more than $66,236.76. Insiders at Anixa Biosciences own 22.6% of the company. Learn More about insider trades at Anixa Biosciences.
Information on this page was last updated on 7/30/2024.

Amit Kumar Insider Trading History at Anixa Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/7/2024	Buy	25,000	$2.41	$60,250.00	516,925
3/15/2024	Buy	30,000	$3.22	$96,600.00	491,925
7/31/2023	Sell	11,800	$3.57	$42,126.00	461,925
1/7/2022	Buy	20,000	$3.00	$60,000.00
10/29/2021	Buy	2,000	$4.77	$9,540.00
7/23/2021	Buy	5,000	$4.28	$21,400.00	292,000
3/25/2021	Buy	5,000	$4.86	$24,300.00	277,000
1/29/2021	Buy	10,000	$3.73	$37,300.00	272,000
9/11/2020	Buy	28,000	$2.11	$59,080.00	262,000
6/12/2020	Buy	20,000	$2.03	$40,600.00	234,000
1/14/2020	Buy	20,000	$2.99	$59,800.00	194,000
9/13/2019	Buy	10,000	$4.12	$41,200.00
4/26/2019	Buy	4,000	$4.21	$16,840.00
4/24/2019	Buy	10,000	$4.27	$42,700.00
10/25/2018	Buy	11,000	$3.90	$42,900.00

Amit Kumar Buying and Selling Activity at Anixa Biosciences

Anixa Biosciences Company Overview

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Today's Range

Now: $3.20

$3.18

$3.65

50 Day Range

MA: $3.25

$2.99

$3.97

2 Week Range

Now: $3.20

$2.14

$5.13

Volume

627,854 shs

Average Volume

110,837 shs

Market Capitalization

$102.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Amit Kumar Biography and Net Worth

What is Amit Kumar's net worth?

How old is Amit Kumar?

What is Amit Kumar's salary?

How do I contact Amit Kumar?

Has Amit Kumar been buying or selling shares of Anixa Biosciences?

Who are Anixa Biosciences' active insiders?

Are insiders buying or selling shares of Anixa Biosciences?